Zimmer Biomet Holdings (ZBH) Stock Statistics & Valuation Metrics

Zimmer Biomet Holdings has a market cap or net worth of $18.78B. The enterprise value is $26.41B.

Zimmer Biomet Holdings has 198,181,550 shares outstanding. The number of shares has decreased by -2.65% in one year.

Zimmer Biomet Holdings’s return on equity (ROE) is 0.07 and return on invested capital (ROIC) is 5.68%.

The current PE Ratio of Zimmer Biomet Holdings is 23.4. Zimmer Biomet Holdings’s PEG ratio is -2.53.

In the last 12 months, Zimmer Biomet Holdings had revenue of 7.68B and earned 903.80M in profits. Earnings per share was 4.45.

In the last 12 months, operating cash flow was 1.69B and capital expenditures -84.90M, giving a free cash flow of 1.60B billion.

Zimmer Biomet Holdings pays an annual dividend of $0.24, resulting in a dividend yield of 1.01%

Zimmer Biomet Holdings upcoming earnings date is Feb 5, 2026, Before Open (Confirmed).

Zimmer Biomet Holdings as a current ratio of 1.91, with Debt / Equity ratio of 57.24%

In the past 12 months, Zimmer Biomet Holdings has paid 131.40M in taxes.

Zimmer Biomet Holdings EV to EBITDA ratio is 12.05, with an EV/FCF ratio of 23.75.

Zimmer Biomet Holdings has $1.29B in cash and marketable securities with $8.11B in debt, giving a net cash position of -$6.82B billion.

Gross margin is 71.44%, with operating margin of 16.74%, and net profit margin of 11.77%.

The average price target for Zimmer Biomet Holdings is $103.38, which is 11.43% higher than the current price. The consensus rating is Hold